You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凱萊英(002821.SZ):全資子公司擬1億元在上海奉賢設立奉賢凱萊英
格隆匯 03-04 18:01

格隆匯3月4日丨凱萊英(002821.SZ)公佈,公司資子公司上海凱萊英生物技術有限公司擬以自有資金1億元人民幣在上海奉賢設立的全資子公司上海凱萊英生物製藥有限公司(名稱以工商登記為準,以下簡稱“奉賢凱萊英”),主要從事包括新型抗體藥物、抗體偶聯藥物(ADC)等在內的生物藥的CDMO研發與生產服務。奉賢凱萊英的設立,將進一步提升凱萊英新業務賽道的服務能力,助力公司戰略佈局的實現。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account